Nutex Health president exercises RSUs, pays taxes

Nutex Health Inc. president Warren Hosseinion reported routine equity compensation activity.

Rhea-AI Filing Summary

Nutex Health Inc. president Warren Hosseinion reported routine equity compensation activity. He exercised 3,656 restricted stock units, which convert into common stock on a one-for-one basis, and received 6,293 common shares upon vesting. Of those shares, 3,274 were delivered at a price of 86.2224 per share to cover tax withholding obligations. Following these transactions, he holds 7,513 shares of common stock directly and 15,739 restricted stock units that remain outstanding and unexercised, which are scheduled to vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Insider Trade Summary

3,656 shares exercised/converted

Exercise 3 txns

Insider Hosseinion Warren

Role President

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	3,656	$0.00	$0.00
Exercise	Common Stock	6,293	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	3,274	$86.2224	$282K

Holdings After Transaction: Restricted Stock Units — 15,739 contracts (Direct); Common Stock — 7,513 shares (Direct)

Footnotes (3)

1. F1. Restricted stock units convert into common stock on a one-for-one basis.
2. F2. Of the 6,293 shares issued subsequent to vesting, 3,274 shares were sold to cover tax withholding obligations.
3. F3. On March 11, 2026, the Reporting Person was granted 3,656 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Nutex Health (NUTX) report for Warren Hosseinion?

Nutex Health reported that president Warren Hosseinion exercised 3,656 restricted stock units into common stock and received 6,293 common shares upon vesting. Of those, 3,274 shares were delivered to satisfy tax withholding obligations related to the equity compensation event.

How many Nutex Health (NUTX) shares does Warren Hosseinion hold after this Form 4?

After these transactions, Warren Hosseinion directly holds 7,513 shares of Nutex Health common stock. He also has 15,739 restricted stock units outstanding, which represent additional potential shares that will be delivered as the awards vest over the specified future dates.

Were any of Warren Hosseinion’s Nutex Health (NUTX) shares sold on the open market?

The filing shows a disposition of 3,274 Nutex Health shares coded as a tax-withholding transaction at 86.2224 per share. This reflects shares delivered to cover tax obligations, not an open-market sale initiated for investment or portfolio management reasons.

What new equity awards did Warren Hosseinion receive from Nutex Health (NUTX)?

On March 11, 2026, Warren Hosseinion was granted 3,656 restricted stock units by Nutex Health. These RSUs vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029, providing staged future share delivery tied to continued service.

How do the restricted stock units for Nutex Health (NUTX) convert into shares?

The filing states that restricted stock units convert into Nutex Health common stock on a one-for-one basis. This means each vested RSU delivers one share of common stock, aligning the value of the award directly with the company’s equity performance over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 05:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hosseinion Warren

(Last) (First) (Middle)

1776 YORKTOWN STREET

SUITE 700

(Street)

HOUSTON TX 77056

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		M		6,293(1)	A	$0(1)	10,787	D
Common Stock	03/10/2026		F		3,274(2)	D	$86.2224	7,513	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(1)	03/10/2026		M		3,656(1)		03/01/2027(3)	03/01/2029(3)	Common Stock	3,656(3)	$0	15,739	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. Of the 6,293 shares issued subsequent to vesting, 3,274 shares were sold to cover tax withholding obligations.

3. On March 11, 2026, the Reporting Person was granted 3,656 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

	/s/ Warren Hosseinion	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.